These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 25892862

  • 21. Aliskiren reduces portal pressure in portal hypertensive rats.
    Chang CC, Lee WS, Huang HC, Lee FY, Wang SS, Lin HC, Nong JY, Lee SD.
    Eur J Clin Invest; 2012 May; 42(5):526-33. PubMed ID: 22023532
    [Abstract] [Full Text] [Related]

  • 22. Tumor necrosis factor alpha signaling in the development of experimental murine pre-hepatic portal hypertension.
    Theodorakis NG, Wang YN, Wu J, Maluccio MA, Skill NJ.
    Int J Physiol Pathophysiol Pharmacol; 2010 Mar 08; 2(2):104-110. PubMed ID: 21383890
    [Abstract] [Full Text] [Related]

  • 23. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model.
    Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Tanoue K, Sugimachi K.
    Scand J Gastroenterol; 2000 Oct 08; 35(10):1097-105. PubMed ID: 11099065
    [Abstract] [Full Text] [Related]

  • 24. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E, Trebicka J, Kang A, Hennenberg M, Sauerbruch T, Heller J.
    Liver Int; 2008 Mar 08; 28(3):331-8. PubMed ID: 18290775
    [Abstract] [Full Text] [Related]

  • 25. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
    Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ.
    Gastroenterology; 2003 Nov 08; 125(5):1452-61. PubMed ID: 14598261
    [Abstract] [Full Text] [Related]

  • 26. Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat.
    Kaviani A, Ohta M, Itani R, Sander F, Tarnawski AS, Sarfeh IJ.
    J Gastrointest Surg; 1997 Nov 08; 1(4):371-6. PubMed ID: 9834372
    [Abstract] [Full Text] [Related]

  • 27. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M, Rodriguez S, Raurell I, Ezkurdia N, Brull A, Augustin S, Guardia J, Esteban R, Martell M, Genescà J.
    Hepatology; 2012 Nov 08; 56(5):1849-60. PubMed ID: 22610782
    [Abstract] [Full Text] [Related]

  • 28. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
    Anegawa G, Kawanaka H, Yoshida D, Konishi K, Yamaguchi S, Kinjo N, Taketomi A, Hashizume M, Shimokawa H, Maehara Y.
    Hepatology; 2008 Mar 08; 47(3):966-77. PubMed ID: 18167063
    [Abstract] [Full Text] [Related]

  • 29. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T, Otani H, Yoshioka K, Fujita M, Okazaki T, Iwasaka T.
    Am J Physiol Heart Circ Physiol; 2011 Nov 08; 301(5):H2061-72. PubMed ID: 21890687
    [Abstract] [Full Text] [Related]

  • 30. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
    Biecker E, Neef M, Sägesser H, Shaw S, Koshy A, Reichen J.
    Liver Int; 2004 Aug 08; 24(4):345-53. PubMed ID: 15287858
    [Abstract] [Full Text] [Related]

  • 31. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
    Hu L, Su L, Dong Z, Wu Y, Lv Y, George J, Wang J.
    J Mol Med (Berl); 2019 Mar 08; 97(3):423-434. PubMed ID: 30721324
    [Abstract] [Full Text] [Related]

  • 32. The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.
    Guo J, Breen DM, Pereira TJ, Dalvi PS, Zhang H, Mori Y, Ghanim H, Tumiati L, Fantus IG, Bendeck MP, Dandona P, Rao V, Dolinsky VW, Heximer SP, Giacca A.
    Atherosclerosis; 2015 Jul 08; 241(1):111-20. PubMed ID: 25974101
    [Abstract] [Full Text] [Related]

  • 33. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T, Payer BA, Schwabl P, Hayden H, Horvatits T, Jäger B, Hummel T, Mitterhauser M, Trauner M, Fuhrmann V, Angermayr B, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    Liver Int; 2013 Apr 08; 33(4):561-8. PubMed ID: 23331709
    [Abstract] [Full Text] [Related]

  • 34. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.
    Deng W, Duan M, Qian B, Zhu Y, Lin J, Zheng L, Zhang C, Qi X, Luo M.
    Clin Res Hepatol Gastroenterol; 2019 Jun 08; 43(3):255-265. PubMed ID: 30413372
    [Abstract] [Full Text] [Related]

  • 35. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats.
    Hori N, Wiest R, Groszmann RJ.
    Hepatology; 1998 Dec 08; 28(6):1467-73. PubMed ID: 9828208
    [Abstract] [Full Text] [Related]

  • 36. Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension.
    Yang YY, Lin HC, Huang YT, Lee TY, Hou MC, Lee FY, Liu RS, Chang FY, Lee SD.
    J Hepatol; 2002 May 08; 36(5):600-6. PubMed ID: 11983442
    [Abstract] [Full Text] [Related]

  • 37. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats.
    Luo B, Liu L, Tang L, Zhang J, Ling Y, Fallon MB.
    Am J Physiol Gastrointest Liver Physiol; 2004 Feb 08; 286(2):G294-303. PubMed ID: 14715521
    [Abstract] [Full Text] [Related]

  • 38. Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.
    Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M.
    J Hepatol; 2009 Nov 08; 51(5):865-73. PubMed ID: 19726100
    [Abstract] [Full Text] [Related]

  • 39. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chu CJ, Wu SL, Lee FY, Wang SS, Chang FY, Lin HC, Chan CC, Lee SD.
    Clin Sci (Lond); 2000 Dec 08; 99(6):475-82. PubMed ID: 11099389
    [Abstract] [Full Text] [Related]

  • 40. N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.
    Licks F, Hartmann RM, Marques C, Schemitt E, Colares JR, Soares Mdo C, Reys J, Fisher C, da Silva J, Marroni NP.
    World J Gastroenterol; 2015 Nov 21; 21(43):12351-60. PubMed ID: 26604642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.